Today’s innovative medicines are treating diseases in ways thought unimaginable just a decade ago, but too often, patients have to fight to get the treatments they need. Sometimes insurers won't pay for new medicines because they question the medicine’s benefits and it’s true that different patients respond differently to different medicines. How we pay for medicines should reflect these differences. That’s why biopharmaceutical companies are working with insurers on innovative and flexible ways to pay for medicines that focus on results, lower out-of-pocket costs and enable patients to access the right treatments the first time.